Kate is a veterinarian by training, specializing in equine health, and a senior Animal Health professional at Boehringer Ingelheim. She has held a variety of roles in clinical drug development, regulatory affairs and business development. With around 20 years of animal health experience, in both clinical and commercial settings, Kate is a firm believer in the power of partnership to accelerate the discovery and development of the next generation of breakthroughs that will improve the health and well-being of animals. Kate is currently Director of Strategic Partnering, with a focus on Cardiometabolic Diseases; Central Nervous System Diseases; Pain and Mobility and Oral Health.